Stellaromics Revenue and Competitors
Estimated Revenue & Valuation
- Stellaromics's estimated annual revenue is currently $8.5M per year.
- Stellaromics's estimated revenue per employee is $189,444
- Stellaromics's total funding is $105M.
Employee Data
- Stellaromics has 45 Employees.
- Stellaromics grew their employee count by 150% last year.
Stellaromics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO and Board Member | Reveal Email/Phone |
3 | Chief Technology Officer and Co-Founder | Reveal Email/Phone |
4 | Co-Founder and Chief Technology Officer | Reveal Email/Phone |
5 | Head People | Reveal Email/Phone |
6 | SVP Product Development & Operations | Reveal Email/Phone |
7 | Head Scientific Services & Collaborations | Reveal Email/Phone |
8 | Senior Director, Computational Biology and Data Science | Reveal Email/Phone |
9 | Sr. Director Assay Development | Reveal Email/Phone |
10 | Business Operations Manager | Reveal Email/Phone |
Stellaromics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Stellaromics?
Founded in 2022 and headquartered in Boston, Stellaromics is revolutionizing biomedical research with its proprietary technology, unraveling complex 3D transcription and translation patterns within native biological tissue. At the forefront of their innovation is STARmap (Spatially-resolved Transcript Amplicon Readout mapping), their flagship product. STARmap empowers researchers to uncover gene expression patterns within intact tissue, facilitating the pinpointing of treatment targets and bolstering biomedical investigations.\n\nStellaromics is currently in the advanced stages of developing its Pyxa™ suite of products, meticulously crafted to empower researchers and clinicians in the creation of intricate cellular maps, thereby amplifying our comprehension of various diseases.\n\nFor comprehensive details, we invite you to explore our website at stellaromics.com. Join us in shaping the future of biomedical research.\n\n \n\n \n \n Show more\n \n\n \n\n\n \n \n Show less
keywords:N/A
$105M
Total Funding
45
Number of Employees
$8.5M
Revenue (est)
150%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Boston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.5M | 45 | -20% | $21.6M |
#2 | $4.8M | 45 | -8% | $16.8M |
#3 | $3.7M | 45 | -59% | N/A |
#4 | $11.6M | 45 | -12% | N/A |
#5 | $7M | 45 | 29% | N/A |